Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.
Year: 1996
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1831044128
